Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D Chey

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
The American Journal of Gastroenterology|October 8, 1997
Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trialW D Chey, L Fisher, G H Elta, et al.
Alimentary Pharmacology & Therapeutics|July 20, 2007
Oesophageal hypersensitivity is associated with features of psychiatric disorders and the irritable bowel syndromeJ H Rubenstein, B Nojkov, S Korsnes, et al.
The American Journal of Gastroenterology|November 6, 2001
Can endoscopic ultrasound or magnetic resonance cholangiopancreatography replace ERCP in patients with suspected biliary disease? A prospective trial and cost analysisJ M Scheiman, R C Carlos, J L Barnett, et al.
The American Journal of Gastroenterology|February 3, 1998
The ChemTrak Hp Chek fingerstick whole blood serology test for the detection of Helicobacter pylori infectionW D Chey, U K Murthy, W Linscheer, et al.
Alimentary Pharmacology & Therapeutics|November 3, 2012
Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpointsE M M Quigley, J Tack, W D Chey, et al.
Neurogastroenterology and Motility|May 26, 2017
Development and validation of the Patient-Physician Relationship Scale among patients with irritable bowel syndromeJ E Kurlander, W D Chey, C B Morris, et al.
Alimentary Pharmacology & Therapeutics|September 16, 2009
Measuring irritable bowel syndrome patient-reported outcomes with an abdominal pain numeric rating scaleB Spiegel, R Bolus, L A Harris, et al.
Alimentary Pharmacology & Therapeutics|September 3, 2010
Characterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practiceB M R Spiegel, R Bolus, L A Harris, et al.
Alimentary Pharmacology & Therapeutics|February 24, 2012
Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disordersJ Tack, M Camilleri, L Chang, et al.
Alimentary Pharmacology & Therapeutics|October 20, 2010
Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trialsB M R Spiegel, R Bolus, N Agarwal, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
The American Journal of Gastroenterology|October 8, 1997
Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trialW D Chey, L Fisher, G H Elta, et al.
Alimentary Pharmacology & Therapeutics|July 20, 2007
Oesophageal hypersensitivity is associated with features of psychiatric disorders and the irritable bowel syndromeJ H Rubenstein, B Nojkov, S Korsnes, et al.
The American Journal of Gastroenterology|November 6, 2001
Can endoscopic ultrasound or magnetic resonance cholangiopancreatography replace ERCP in patients with suspected biliary disease? A prospective trial and cost analysisJ M Scheiman, R C Carlos, J L Barnett, et al.
The American Journal of Gastroenterology|February 3, 1998
The ChemTrak Hp Chek fingerstick whole blood serology test for the detection of Helicobacter pylori infectionW D Chey, U K Murthy, W Linscheer, et al.
Alimentary Pharmacology & Therapeutics|November 3, 2012
Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpointsE M M Quigley, J Tack, W D Chey, et al.
Neurogastroenterology and Motility|May 26, 2017
Development and validation of the Patient-Physician Relationship Scale among patients with irritable bowel syndromeJ E Kurlander, W D Chey, C B Morris, et al.
Alimentary Pharmacology & Therapeutics|September 16, 2009
Measuring irritable bowel syndrome patient-reported outcomes with an abdominal pain numeric rating scaleB Spiegel, R Bolus, L A Harris, et al.
Alimentary Pharmacology & Therapeutics|September 3, 2010
Characterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practiceB M R Spiegel, R Bolus, L A Harris, et al.
Alimentary Pharmacology & Therapeutics|February 24, 2012
Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disordersJ Tack, M Camilleri, L Chang, et al.
Alimentary Pharmacology & Therapeutics|October 20, 2010
Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trialsB M R Spiegel, R Bolus, N Agarwal, et al.
Pageof 7